Evidence map›Paper›PMID 32811815›Full record

ArticleCell death & disease2020

LXA

Hyunjung Kim, Sung-Hyo Park, Song Yee Han, Yun-Sil Lee, Jaeho Cho, Jin-Mo Kim

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. [Mefloquine HCl promotes DNA repair and alleviates radiation-induced lung epithelial cell injury].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Lipoxin AFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Lipoxin AFrontiers in immunology · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Hyunjung KimDepartment of Radiation Oncology, Yonsei University College of Medicine, Seoul, South Korea.
Sung-Hyo ParkDepartment of Radiation Oncology, Yonsei University College of Medicine, Seoul, South Korea.
Song Yee HanDepartment of Radiation Oncology, Yonsei University College of Medicine, Seoul, South Korea.
Yun-Sil LeeGraduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, South Korea.ORCID http://orcid.org/0000-0002-7538-8850
Jaeho ChoDepartment of Radiation Oncology, Yonsei University College of Medicine, Seoul, South Korea. jjhmd@yuhs.ac.
Jin-Mo KimDepartment of Radiation Oncology, Yonsei University College of Medicine, Seoul, South Korea. jmk0831@snu.ac.kr.
Yonsei University · KREwha Womans University · KRSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation therapy is an important modality in the treatment of lung cancer, but it can lead to radiation pneumonitis, and eventually radiation fibrosis. To date, only few available drugs can effectively manage radiation-induced pulmonary fibrosis. Lipoxins are endogenous molecules exhibit anti-inflammatory and pro-resolving effects. These molecules play a vital role in reducing excessive tissue injury and chronic inflammation; however, their effects on radiation-induced lung injury (RILI) are unknown. In this study, we investigated the effects of lipoxin A

Indexed as

AnimalsAnti-Inflammatory AgentsCytokinesFibrosisHumansLipoxinsLungMaleMiceMice, Inbred C57BLPulmonary FibrosisRadiationRadiotherapyReceptor Cross-TalkReceptors, Formyl PeptideReceptors, LipoxinAnti-Inflammatory AgentsCytokinesformyl peptide receptor 2, mouseFPR2 protein, humanlipoxin A4LipoxinsReceptors, Formyl PeptideReceptors, LipoxinSmad ProteinsTransforming Growth Factor beta

Identifiers

PMID32811815
PMCPMC7434774
OpenAlexW3053962063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.